Ivacaftor - PDFSEARCH.IO - Document Search Engine

Ivacaftor
Results: 106

#	Item
31	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of ivacaftor (Kalydeco) for cystic fibrosis A stakeholder meeting was held on 31 July 2014 to discuss the Pharmaceutical Benefits Scheme (PBS) listing Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-08-11 03:26:01 Channelopathy Cystic fibrosis Pediatrics Ivacaftor Spirometry Pharmaceutical Benefits Scheme Clinical trial Health Medicine Pulmonology
32	CFTNEWS SPRING[removed]Cystic Fibrosis Tasmania Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2013-05-05 21:05:07 Cystic fibrosis Pediatrics The Alfred Hospital Paula Wriedt Ivacaftor Cystic Fibrosis Trust Health Medicine Channelopathy
33	Session 1: Generating and Interpreting Data in Ultra-rare Patient Subsets in Non-oncologic Diseases Add to Reading List Source URL: www.fda.gov Language: English Ivacaftor Phenols Quinolones Cystic fibrosis transmembrane conductance regulator Cystic fibrosis Vertex Pharmaceuticals Ion channel CFTR Cystic Fibrosis Foundation Biology Health Anilides
34	Typical Patient Questions Regarding Kalydeco Access What patients can access Kalydeco? Patients with the G551D mutation 6 years of age Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-11-06 18:46:00 Patient safety Pharmacology Clinical pharmacology Medical prescription Pharmacy Methadone Ivacaftor Chemistry Pharmaceutical sciences Organic chemistry
35	Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]th Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English Quinolones Vertex Pharmaceuticals Vertex Anilides Ivacaftor Phenols
36	4 July[removed]Update on the PBAC review of KALYDECO™ (ivacaftor) in Australia Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-07-04 02:43:16 Pharmaceutical Benefits Scheme Organic chemistry Ivacaftor Methadone Health Healthcare in Australia Pharmaceuticals policy Chemistry
37	AUTUMN2014 IN THIS ISSUE THE MANY FACES OF CF Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-07-31 02:17:43 Channelopathy Cystic fibrosis Pediatrics Lung transplantation Heart–lung transplant Sweat test Ivacaftor Cystic Fibrosis Trust Cystic Fibrosis Canada Medicine Health Organ transplants
38	MEDIA RELEASE 26 June 2014 For immediate release Positive results from latest clinical trial combining Kalydeco and new drug lumacaftor in people with most common from of cystic fibrosis Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-06-26 02:06:37 Channelopathy Cystic fibrosis Pediatrics Ivacaftor VX-809 Cystic Fibrosis Trust Cystic Fibrosis Foundation Health Organic chemistry Medicine
39	Microsoft Word - CFA_Kalydeco PBS Listing Media Release.docx Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-10-25 18:58:33 Cystic fibrosis Pediatrics Biology Ivacaftor Epithelial sodium channel Cystic Fibrosis Canada Cystic Fibrosis Trust Health Medicine Channelopathy
40	Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]October 2014 Add to Reading List Source URL: www.cysticfibrosis.org.au Language: English - Date: 2014-10-25 19:53:08 Ivacaftor Phenols Quinolones Vertex Pharmaceuticals Cystic fibrosis Pharmaceutical Benefits Scheme Health Medicine Anilides